209 related articles for article (PubMed ID: 25824865)
1. Hospitalization rates and utilization among patients with giant cell arteritis: A population-based study from 1987 to 2012.
Michet CJ; Achenbach SJ; Crowson CS; Matteson EL
Semin Arthritis Rheum; 2015 Aug; 45(1):70-4. PubMed ID: 25824865
[TBL] [Abstract][Full Text] [Related]
2. Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis.
Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
Semin Arthritis Rheum; 2017 Apr; 46(5):650-656. PubMed ID: 27839741
[TBL] [Abstract][Full Text] [Related]
3. Occupational and socio-economic risk factors for giant cell arteritis: a nationwide study based on hospitalizations in Sweden.
Zöller B; Li X; Sundquist J; Sundquist K
Scand J Rheumatol; 2013; 42(6):487-97. PubMed ID: 23815287
[TBL] [Abstract][Full Text] [Related]
4. Hospitalized infections in giant cell arteritis: a population-based retrospective cohort study.
Udayakumar PD; Chandran AK; Crowson CS; Warrington KJ; Matteson EL
J Rheumatol; 2014 Dec; 41(12):2447-51. PubMed ID: 25320223
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Cardiovascular Hospitalization in Giant Cell Arteritis: Effect of Statin Exposure. A French Population-based Study.
Pugnet G; Sailler L; Fournier JP; Bourrel R; Montastruc JL; Lapeyre-Mestre M
J Rheumatol; 2016 Dec; 43(12):2162-2170. PubMed ID: 27585686
[TBL] [Abstract][Full Text] [Related]
6. Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based study.
Ninan J; Nguyen AM; Cole A; Rischmueller M; Dodd T; Roberts-Thomson P; Hill CL
J Rheumatol; 2011 Oct; 38(10):2215-7. PubMed ID: 21844141
[TBL] [Abstract][Full Text] [Related]
7. Incidence of infections in patients with giant cell arteritis: a cohort study.
Durand M; Thomas SL
Arthritis Care Res (Hoboken); 2012 Apr; 64(4):581-8. PubMed ID: 22184094
[TBL] [Abstract][Full Text] [Related]
8. Healthcare Use and Direct Cost of Giant Cell Arteritis: A Population-based Study.
Koster MJ; Achenbach SJ; Crowson CS; Maradit-Kremers H; Matteson EL; Warrington KJ
J Rheumatol; 2017 Jul; 44(7):1044-1050. PubMed ID: 28461641
[TBL] [Abstract][Full Text] [Related]
9. Burden, Causes, and Outcomes of Hospitalization in Patients With Giant Cell Arteritis: A US National Cohort Study.
Goulabchand R; Qian AS; Nguyen NH; Singh AG; Roubille C; Parreau S; Singh N; Singh S
Arthritis Care Res (Hoboken); 2023 Aug; 75(8):1830-1837. PubMed ID: 36576029
[TBL] [Abstract][Full Text] [Related]
10. Hospitalization rates and utilization among patients with rheumatoid arthritis: a population-based study from 1987 to 2012 in Olmsted County, Minnesota.
Michet CJ; Strobova K; Achenbach S; Crowson CS; Matteson EL
Mayo Clin Proc; 2015 Feb; 90(2):176-83. PubMed ID: 25659235
[TBL] [Abstract][Full Text] [Related]
11. Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study.
Mohammad AJ; Englund M; Turesson C; Tomasson G; Merkel PA
J Rheumatol; 2017 Jan; 44(1):84-90. PubMed ID: 27803140
[TBL] [Abstract][Full Text] [Related]
12. Trajectory of Healthcare Resource Utilization in Giant Cell Arteritis: A Population-based Study.
Mohammad AJ; Turkiewicz A; Stamatis P; Turesson C; Englund M; Kiadaliri A
J Rheumatol; 2021 Aug; 48(8):1307-1313. PubMed ID: 33649063
[TBL] [Abstract][Full Text] [Related]
13. The Detection of Rheumatic Disease through Hospital Diagnoses with Examples of Rheumatoid Arthritis and Giant Cell Arteritis: What Are We Missing?
John Michet C; Crowson CS; Achenbach SJ; Matteson EL
J Rheumatol; 2015 Nov; 42(11):2071-4. PubMed ID: 26233503
[TBL] [Abstract][Full Text] [Related]
14. Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.
Brekke LK; Diamantopoulos AP; Fevang BT; Aβmus J; Esperø E; Gjesdal CG
Arthritis Res Ther; 2017 Dec; 19(1):278. PubMed ID: 29246164
[TBL] [Abstract][Full Text] [Related]
15. Mortality in patients with giant cell arteritis.
Baslund B; Helleberg M; Faurschou M; Obel N
Rheumatology (Oxford); 2015 Jan; 54(1):139-43. PubMed ID: 25122725
[TBL] [Abstract][Full Text] [Related]
16. Mortality in Patients With Giant Cell Arteritis: A Cohort Study in UK Primary Care.
Li L; Neogi T; Jick S
Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1251-1256. PubMed ID: 29409137
[TBL] [Abstract][Full Text] [Related]
17. The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950-2009.
Chandran AK; Udayakumar PD; Crowson CS; Warrington KJ; Matteson EL
Scand J Rheumatol; 2015 May; 44(3):215-8. PubMed ID: 25606666
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Severe Infections and Infection-Related Mortality During the Course of Giant Cell Arteritis: A Multicenter, Prospective, Double-Cohort Study.
Schmidt J; Smail A; Roche B; Gay P; Salle V; Pellet H; Duhaut P
Arthritis Rheumatol; 2016 Jun; 68(6):1477-82. PubMed ID: 26815885
[TBL] [Abstract][Full Text] [Related]
19. Inpatient complications in patients with giant cell arteritis: decreased mortality and increased risk of thromboembolism, delirium and adrenal insufficiency.
Unizony S; Menendez ME; Rastalsky N; Stone JH
Rheumatology (Oxford); 2015 Aug; 54(8):1360-8. PubMed ID: 25667435
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell Arteritis.
Chen JJ; Leavitt JA; Fang C; Crowson CS; Matteson EL; Warrington KJ
Ophthalmology; 2016 Sep; 123(9):1999-2003. PubMed ID: 27297405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
